Performance of amide proton transfer imaging to differentiate true progression from therapy-related changes in gliomas and metastases.

Therapy-related changes mimicking progression complicate brain tumour treatment. Amide proton imaging improves the non-invasive discrimination of glioma progression from therapy-related changes. Magnetisation transfer ratio asymmetry measurement seems not to have added value in brain metastases.